The CDC and the American Academy of Pediatrics recommend the RSV monoclonal antibody treatment Beyfortus for babies under 8 ...

NEW YORK, NY, UNITED STATES, January 7, 2026 /EINPresswire.com/ -- Public health expert Dr. Syra Madad and Critical ...

In 2023, the FDA and CDC's Advisory Committee on Immunization Practices (ACIP) voted in favor of recommending the monoclonal ...

Peak season ranges from late December to mid-February every year, the CDC website says. Last year in North Carolina, RSV ...

Nirsevimab, a long-acting monoclonal antibody that confers passive immunity for infants up to 6 months old, was approved in ...

Infants who receive nirsevimab may have a lower risk for hospitalisation for RSV-related lower respiratory tract infection ...

Against a backdrop of explosive nationwide growth in flu activity that area hospitals call still just "a steady increase" ...

Flu, COVID and RSV are circulating as cases increase locally. Amarillo health leaders explain what protection still works now ...

Flu and respiratory illness activity hits its peak across the country and Louisiana is reporting very high and increasing ...

For pregnant women who received the bivalent prefusion F subunit-based respiratory syncytial virus (RSV) vaccine (RSVpreF; ...

An analysis of safety data suggests that Abrysvo, the Pfizer respiratory syncytial virus (RSV) RSVpreF vaccine, does not ...